1. Home
  2. FIGR vs KRYS Comparison

FIGR vs KRYS Comparison

Compare FIGR & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FIGR

Figure Technology Solutions Inc.

N/A

Current Price

$32.08

Market Cap

7.7B

Sector

Finance

ML Signal

N/A

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$267.27

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIGR
KRYS
Founded
2018
2015
Country
United States
United States
Employees
602
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
7.8B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
FIGR
KRYS
Price
$32.08
$267.27
Analyst Decision
Buy
Strong Buy
Analyst Count
9
11
Target Price
$53.22
$297.60
AVG Volume (30 Days)
3.9M
225.0K
Earning Date
05-11-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
128.00
EPS
N/A
6.84
Revenue
N/A
$389,130,000.00
Revenue This Year
$69.23
$38.74
Revenue Next Year
$24.25
$32.53
P/E Ratio
$134.36
$40.09
Revenue Growth
N/A
33.94
52 Week Low
$25.01
$123.03
52 Week High
$78.00
$298.30

Technical Indicators

Market Signals
Indicator
FIGR
KRYS
Relative Strength Index (RSI) 42.77 52.72
Support Level $25.01 $254.53
Resistance Level $34.93 $297.14
Average True Range (ATR) 2.23 8.03
MACD 0.08 1.17
Stochastic Oscillator 23.52 57.98

Price Performance

Historical Comparison
FIGR
KRYS

About FIGR Figure Technology Solutions Inc.

Figure Technology Solutions Inc is building the future of capital markets with blockchain technology. proprietary technology powers next-generation lending, trading, and investing activities in areas such as consumer credit and digital assets. Its use of the blockchain ledger allows them to serve their end customers, improve speed and efficiency, and enhance standardization and liquidity. The Company operates as a single operating and reportable segment. The company's geographical operations is within the USA, with the majority of revenue from California.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: